VUFB 15496Alternative Names: Cloflumide
Latest Information Update: 14 Apr 2010
At a glance
- Originator VUFB
- Developer Zentiva
- Class Antipsychotics
- Mechanism of Action Dopamine receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 13 Feb 2001 Suspended-Preclinical for Psychotic disorders in Czech Republic (Unknown route)
- 10 Feb 1997 No-Development-Reported for Psychotic disorders in Czech Republic (Unknown route)